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Viral replication compartmentsor and DNA replication protein encoded by the Epstein–Barr virus (EBV) BZLF1
gene, plays indispensable roles in the EBV lytic cycle. We recently described the phenotypes of 46 single
amino acid substitutions introduced into the DNA-recognition region of ZEBRA [Heston, L., El-Guindy, A.,
Countryman, J., Dela Cruz, C., Delecluse, H.J., and Miller, G. 2006]. The 27 DNA-binding-proﬁcient mutants
exhibited distinct defects in their ability to activate expression of the kinetic classes of viral genes. Four
phenotypic variants could be discerned: wild-type, defective at activating Rta, defective at activating early
genes, and defective at activating late genes. Here we analyze the distribution of ZEBRA within the nucleus
and the localization of EA-D (the viral DNA polymerase processivity factor), an indicator of the development
of replication compartments, in representatives of each phenotypic group. Plasmids encoding wild-type
(WT) and mutant ZEBRA were transfected into 293 cells containing EBV-bacmids. WT ZEBRA protein was
diffusely and smoothly distributed throughout the nucleus, sparing nucleoli, and partially recruited to
globular replication compartments. EA-D induced by WT ZEBRA was present diffusely in some cells and
concentrated in globular replication compartments in other cells. The distribution of ZEBRA and EA-D
proteins was identical to WT following transfection of K188R, a mutant with a conservative change. The
distribution of S186A mutant ZEBRA protein, defective for activation of Rta and EA-D, was identical to WT,
except that the mutant ZEBRA was never found in globular compartments. Co-expression of Rta with S186A
mutant rescued diffuse EA-D but not globular replication compartments. The most striking observation was
that several mutant ZEBRA proteins defective in activating EA-D (R179A, K181A and A185V) and defective in
activating lytic viral DNA replication and late genes (Y180E and K188A) were localized to numerous punctate
foci. The speckled appearance of R179A and Y180E was more regular and clearly deﬁned in EBV-positive than
in EBV-negative 293 cells. The Y180E late-mutant induced EA-D, but prevented EA-D from localizing to
globular replication compartments. These results show that individual amino acids within the basic domain
inﬂuence localization of the ZEBRA protein and its capacity to induce EA-D to become located in mature viral
replication compartments. Furthermore, these mutant ZEBRA proteins delineate several stages in the
processes of nuclear re-organization which accompany lytic EBV replication.
© 2008 Elsevier Inc. All rights reserved.IntroductionEpstein–Barr virus (EBV) infection of the host begins in oral and
pharyngeal epithelia where the virus replicates in a lytic manner. The
virus subsequently spreads to B lymphocytes where it persists in a
latent state for the lifetime of the host. (Rickinson and Kieff, 1996).
During latency, EBV gene expression is restricted to a subset of viral
genes and no new infectious virus is produced. The production ofs, Yale University School of
Fax: +1 203 785 6961.
l rights reserved.infectious virus and propagation of the virus from cell to cell and host
to host is dependent upon the reactivation of a subpopulation of latent
EBV genomes into the lytic phase of infection. In the lytic phase, a
sequential cascade of viral gene expression results in a 100–1000 fold
ampliﬁcation of the EBV genome, packaging of unit-length viral
genomes into capsids, tegumentation, envelopment, the release of
infectious virions, and, eventually, host cell lysis. The switch from the
latent to lytic phases is triggered by a major viral regulatory protein,
ZEBRA, encoded by the BZLF1 gene (Countryman and Miller, 1985).
ZEBRA is sufﬁcient to disrupt EBV latency and to initiate the lytic
program in all cell types, and is also required for continued
progression of the lytic program through viral late gene expression.
146 R. Park et al. / Virology 382 (2008) 145–162ZEBRA is a 245 amino acid phosphoprotein belonging to the basic
zipper (bZIP) family of proteins. Like other bZIP proteins, ZEBRA
contains a transactivation domain (aa 1 to 166), a basic DNA-
recognition region (aa 178 to 194), and a coiled-coil dimerization
domain (aa195 to 225) (Farrell et al. 1989; Chang and Liu, 2000; Chi
and Carey, 1993; Flemington and Speck, 1990; Flemington et al., 1992;
Taylor et al., 1991). Unlike cellular bZIP proteins, ZEBRA contains a C-
terminal “tail” which may stabilize the homodimer (Petosa et al.,Fig. 1. Intra-nuclear distribution of ZEBRA, EA-D, Rta and nucleolar proteins during lytic ac
transfected with wild-type ZEBRA and double stained for ZEBRA (iii, vi) and EA-D (i, ii, iv, v); Z
(xiii–xvi). Digital images of single channel emissions and simultaneous EA-D-transmitted lig
reduced or increased ZEBRA staining, respectively.2006). ZEBRA performsmany functions necessary for lytic replication:
(i) as a transcription factor, ZEBRA binds to heptamer motifs, termed
ZEBRA response elements (ZRE's), located within the promoters of
lytic viral genes and activates gene expression. Some genes, such as
BRLF1, encoding another viral transcription factor, Rta, are activated
independently by ZEBRA. Other genes, such as BMRF1, encoding the
DNA polymerase processivity factor, are activated by ZEBRA in synergy
with Rta (Liu and Speck, 2003; Feederle et al., 2000; Lieberman et al.,tivation of 293 cells containing EBV-bacmids. BZKO (i–iii) and 2089 cells (iv–xvi) were
EBRA (vii, ix) and nucleolin (viii, ix); or ZEBRA (x, xii) and ﬁbrillarin (xi, xii); Rta and EA-D
ht images (ii, v, xiv) are shown. Blue and yellow arrows indicate nuclear sub-regions of
147R. Park et al. / Virology 382 (2008) 145–1621990; Quinlivan et al., 1993). (ii) As an essential DNA replication
protein, ZEBRA binds directly to the origin of lytic DNA replication
(oriLyt) which contains seven ZRE's. Binding of ZEBRA to oriLyt is
regulated by phosphorylation of residue S173 (El-Guindy et al., 2007).
Binding of ZEBRA to oriLyt is a prerequisite for viral DNA replication,
and is believed to recruit and stabilize components of the core viral
replication complex at oriLyt (Fixman et al., 1995; Hammerschmidt
and Sugden, 1988; Schepers et al., 1993, 1996). A direct physical
interaction between ZEBRA and several viral replication proteins
including the viral helicase, primase, primase-associated factor,
polymerase and polymerase processivity factor has been demon-
strated (Baumann et al., 1999; Gao et al., 1998; Zhang et al., 1996; Liao
et al., 2001). (iii) ZEBRA also induces profound alterations in host cells.
For example, ZEBRA arrests the cell cycle at G0/G1 in EBV-negative
cells (Cayrol and Flemington, 1996). ZEBRA disrupts PML bodies,
causing ND10-associated proteins to disperse during lytic replication
(Adamson and Kenney, 2001; Bell et al., 2000). ZEBRA modulates the
activities of several cellular transcription factors including C/EBP, NF-
KB p65, and c-Myb (Morrison and Kenney, 2004; Morrison et al.,
2004; Kenney et al., 1992; Wu et al., 2003).
Nuclear compartmentalization of lytic viral processes is a
characteristic common to all herpesviruses, including herpes simplex
viruses (HSV), cytomegalovirus (CMV) and EBV. Lytic EBV DNA
synthesis was observed by FISH to occur in discrete intra-nuclear
globular sub-domains (Gradoville et al., 2002), similar to the so-called
replication compartments studied intensively in HSV infection
(Lukonis and Weller, 1996; Liptak et al., 1996). However, the role of
ZEBRA in the formation of these replication compartments has
received little investigation. In detergent-extracted B95-8 cells
containing an inducible BZLF1 gene, ZEBRA protein localized diffusely
throughout the nucleus in a ﬁne-granular staining pattern during theFig. 2. Three distribution patterns of intra-nuclear EA-D in 293 cells containing an EBV-bacm
were selected at random and scored for their EA-D phenotype.early stages of lytic induction. At later stages of infection, after the
onset of viral DNA replication, ZEBRA redistributed from a diffuse
pattern into distinct co-localization with globular EBV replication
compartments (Daikoku et al., 2005). In a separate study, ZEBRA was
present diffusely throughout the nucleus in D98/HR-1 cells transfected
with a BZLF1 expression vector; however ZEBRA did not redistribute to
globular replication compartments (Bell et al., 2000). These differing
observations may be attributed to differences in cell type, detergent
extraction of soluble proteins, or overexpression of ZEBRA.
Previously, we created a comprehensive series of 46 single amino
acid substitutions throughout the basic DNA-recognition region of
ZEBRA and demonstrated that speciﬁc amino acids within this region
play critical and distinct roles in the capacity of ZEBRA to bind DNA, to
activate lytic gene expression, and to promote lytic viral DNA
replication (Heston et al., 2006). Nineteen of the 46 point mutants
which did not bind DNA containing a high afﬁnity ZRE, ZIIIB
completely lost the ability to activate expression of all viral genes
assayed. Twenty-seven ZEBRA mutants retained the capacity to bind
ZIIIB DNA, although with differences in afﬁnity. These DNA-binding-
competent ZEBRAmutants were classiﬁed into four functional groups:
(i) eight mutants were similar to wild-type and showed no defect in
the ability to activate transcription of the Rta gene BRLF1, the early
gene BMRF1, or the late genes BFRF3 and BLRF2. (ii) Nine mutants
were defective in activating Rta expression and all other downstream
genes. (iii) Three mutants were competent to activate Rta expression,
yet were defective in activation of the BMRF1 product, EA-D. (iv)
Seven ZEBRA mutants were not defective in activating Rta or BMRF1
expression, but were unable to promote lytic viral DNA synthesis and
expression of the BFRF3 and BLRF2 late genes.
The alterations of activity resulting from point mutants in the DNA-
recognition region of ZEBRA raised two questions. First, do theseid. 2089 cells were transfected with wild-type ZEBRA, ﬁxed, then stained for EA-D. Cells
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ZEBRA? Second, do the mutations interfere with the formation of
replication compartments? To address these questions, and to further
the understanding of the spatial organization and nuclear compart-
mentalization of EBV lytic processes, we performed a series of indirect
immunoﬂuorescence analyses (IFA) to observe and compare the
distributions of wild-type ZEBRA with mutant forms of ZEBRA. We
also studied the effects of thesemutationsupon thedistributionof EA-D,
a marker for formation of replication compartments. We report here
that point mutations within the basic DNA-binding domain of ZEBRA
cause speciﬁc changes in ZEBRA localization, and affect the formation of
viral replication compartments.Fig. 3. Effect of amino acid substitutions within the basic region on localization of ZEBRA and
cells containing EBV-bacmids. BZKO (i–iii, vii–ix, xiii–xv, xix–xxi) and 2089 (iv–vi, x–xii, xvi–x
stained for ZEBRA and EA-D (i–xxiv) or Rta and EA-D (xxv–xxxvi). (i–vi) S186A Rta-mutan
ZEBRA; (xix–xxiv, xxxi–xxxvi) (K188R) WT-like mutant ZEBRA. Yellow arrow indicates a nuResults
Localization of ZEBRA, Rta and EA-D proteins in lytically induced 293
cells containing wild-type or BZKO mutant EBV-bacmids
Two previous studies of viral protein localization during the EBV
lytic phase using indirect immunoﬂuorescence to analyze anti-IgG-
induced Akata cells (Takagi et al., 1991) or B95-8 cells containing a
tetracycline-inducible BZLF1 gene (Daikoku et al., 2005) described the
accumulation of ZEBRA, EA-D and Rta proteins in distinct intra-
nuclear globular foci. Since these globular structures, usually
numbering 2 to 5 per cell, co-localized with lytically inducedRta, activation of BMRF1 expression, and formation of replication compartments in 293
viii, xxii–xxxvi) cells were transfectedwithmutant ZEBRA constructs, ﬁxed, then double
t ZEBRA; (vii–xii) R179A early-mutant ZEBRA; (xiii–xviii, xxv–xxx) Y180E late-mutant
clear sub-region of increased ZEBRA staining.
Fig. 3 (continued).
149R. Park et al. / Virology 382 (2008) 145–162accumulations of EBV DNA as seen by FISH and with sites of viral DNA
synthesis as seen by BrdU staining, they have been termed replication
compartments. In contrast, studies involving ZEBRA-transfected D98/
HR1 cells described diffuse intra-nuclear staining of ZEBRA with no
evidence of accumulation at replication compartments. (Bell et al.,
2000; Adamson and Kenney, 2001).
To study the effect of mutations in the basic domain of ZEBRA upon
the localization of ZEBRA, and recruitment of ZEBRA and other lytic
EBV proteins to replication compartments, we used a human
embryonic kidney cell line, 293, harboring EBV-bacmids. The bacmids
contained an EBV genome in which the BZLF1 gene was inactivated
(“BZKO”) or the complete EBV genome (“2089”) (Delecluse et al.,
1998). The EBV lytic cycle can be induced in these cells by transfection
of ZEBRA. Point mutants of amino acids in the basic domain of ZEBRA
have unique phenotypes in these cells (Heston et al., 2006). To verifythe utility of this EBV-bacmid system, we ﬁrst observed the
distributions of ZEBRA, Rta, and EA-D proteins during the lytic phase
induced by transfection of full-length wild-type BZLF1 gene fused to a
constitutive CMV promoter (Fig. 1). We found that the distribution of
these three proteins in BZKO cells was indistinguishable from their
distribution in 2089 cells (Fig. 1 and data not shown).
Using the 293 cell/EBV-bacmid system, all ZEBRA-positive cells
showed a ﬁne-granular, relatively smooth textured ZEBRA staining
that was diffuse throughout the nucleus (Fig. 1: panels iii, vi). In
most ZEBRA-positive cells, small sub-regions of decreased or absent
ZEBRA staining were interspersed within the diffuse intra-nuclear
staining (Fig. 1: panels iii, vi; blue arrows). ZEBRA was never
completely recruited to replication compartments in 293 cells with
EBV-bacmids. However, in most cells which showed mature globular
replication compartment formation, as visualized by EA-D staining
Fig. 3 (continued).
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unmistakably increased in areas coincident with the globular
replication compartments (Fig. 1: panel iii; yellow arrow). Thus,
ZEBRA expressed after transfection was diffusely present in the
nucleus and partially recruited to viral replication compartments. In
a minority of cells with formation of globular replication compart-
ments, however, ZEBRA was not increased at sites containing the
globules with EA-D. (Fig. 1: panel vi.).
The intra-nuclear sub-regions of reduced or absent ZEBRA
immunostaining in ZEBRA-positive cells were roughly circular in
shape and resembled the size and outline of nucleoli. To determine if
these regions correspond to nucleoli, 2089 cells transfected with wild-
type ZEBRA were immunostained with antibodies speciﬁc for ZEBRA
and for the nucleolar proteins, nucleolin and ﬁbrillarin. Double
staining with anti-ZEBRA and anti-nucleolin antibodies (Fig. 1: panelsvii-ix) showed that nucleolin localized almost exclusively to the
regions spared of ZEBRA staining. Double staining for ZEBRA and
ﬁbrillarin (Fig. 1: panels x–xii) also showed ﬁbrillarin was found in
regions where ZEBRA staining was absent. Wild-type ZEBRA therefore
localizes diffusely throughout the intra-nuclear space, except that it is
excluded from nucleoli.
In B95-8 cells, Rta has been reported to distribute diffusely
throughout the nucleus at early stages of replication, and to localize
progressively in globular replication compartments, togetherwithEA-D,
at later stages of replication (Daikoku et al., 2005). In 2089 cells, studied
42 h after transfection of wild-type ZEBRA, Rta exhibited a pattern of
localization identical to that of EA-D. Dual staining of EA-D and Rta
showed co-localization of both proteins in discrete globules (Fig. 1:
panels xiii–xvi); in other cells (not shown) both Rta and EA-D were
diffusely distributed or present in non-uniform furrows.
Fig. 4. Phenotype of ZEBRA point mutants in 293 cells containing a wild-type EBV-
bacmid. Shown are panels from immunoblots of 2089 cells which had been transfected
with empty vector (CMV) or vectors containing wild-type ZEBRA (gZ) or ZEBRA point
mutants. The immunoblots were probed with monospeciﬁc antibodies to Rta, EA-D,
ZEBRA (Z), BFRF3 (FR3), and BLRF2 (LR2). The class of each mutant is deﬁned as E: early,
L: late, R: Rta, WT: wild-type.
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EA-D, the EBV DNA polymerase processivity factor, has been shown
to co-localize precisely with globular replication compartments, and
therefore is a useful marker for sites of EBV DNA replication during
lytic phase (Daikoku et al., 2006;Wang et al. 2005; Liao et al., 2001). In
cells doubly stained for EA-D and ZEBRA, all cells which were positive
for EA-D were also positive for ZEBRA; however, EA-D was not
detected in a signiﬁcant number of BZKO cells which were positive for
ZEBRA (see Discussion). There were 3 patterns of distribution of EA-D
observed 42 h after transfection (Fig. 2). In approximately 28% of those
cells which expressed EA-D, the protein was found in discrete intra-
nuclear globular sub-domains, resembling the globular replication
compartments described in earlier reports (Fig. 1: panels i, iv, xiii; Fig.
2: panels iii, vi). The intensely immunoreactive EA-D-positive globules
were often surrounded by a very lightly stained diffuse intra-nuclear
EA-D. The texture of EA-D staining, both within globular replication
compartments and in the surrounding intra-nuclear space was
smooth. In approximately 50% of cells positive for EA-D there was a
diffuse, smooth, ﬁne-grained intra-nuclear texture of the protein
without distinct globule formation (Fig. 2: panels i, iv). In approxi-
mately 22% of cells positive for EA-D the protein was neither diffuse
nor discretely globular, but was non-uniform and furrowed (Fig. 2:
panels ii, v). The different distributions of EA-D staining are likely to
represent different stages of the viral life cycle (see Discussion).
The experiments of Fig. 1 and Fig. 2 demonstrated that localization
of ZEBRA and its capacity to induce replication compartments could
be studied in 293 cells containing EBV-bacmids, a system particularly
suitable for the study of ZEBRA mutants. Furthermore, several stages
of EA-D distribution could be observed after transfection of ZEBRA,
thus allowing a comparison of EA-D distribution following expression
of WT and mutant ZEBRA proteins.
Speciﬁc ZEBRA mutations affect localization of ZEBRA, expression and
localization of EA-D, and formation of replication compartments
Representative ZEBRA mutants from each of four functional
categories were transfected into BZKO or 2089 cells, containing EBV
bacmids, and examined for the localization and morphology of ZEBRA
and EA-D proteins (Fig. 3). The mutants which were studied in this
experiment were: 1) S186A, defective at induction of Rta expression;
2) R179A, active at inducing Rta, but defective at inducing EA-D; 3)
Y180E, active at inducing EA-D, but defective at activating lytic viral
DNA synthesis and late protein expression; and 4) K188R, a mutant
indistinguishable from wild-type (Table 1). For each mutant the
patterns of ZEBRA and EA-D localization in 2089 cells with wild-typeTable 1
Summary of the Phenotypes of ZEBRA mutants used in this study
Mutant Class Binds ZIIB Expression of
indicated protein
ZEBRA
distribution
Replication
compartments
Rta EA-D FR3/LR2
R179A E + + − − Speckles −
Y180E L + + + − Speckles −
K181A R W W − − Speckles −
A185V R W W − − Speckles −
S186A R + − − − Diffuse −
S186E DB − − − − Diffuse −
K188A L + + + − Speckles −
K188R WT + + + + Diffuse +
E=early; fails to activate EA-D.
L=late; fails to activate DNA replication or late genes.
R=Rta; absent or weak induction of Rta.
DB=DNA-binding defect.
WT=wild–type.
W=weak binding or activation.EBV genomes were identical to that seen in BZKO cells with BZLF1-
inactivated genomes.
S186A is a well-studied ZEBRA mutant which is defective at
disruption of latency due to an inability to activate expression of Rta
(Francis et al., 1997). Co-expression of Rta rescues the ability to activate
early gene expression (Adamson and Kenney,1998; Francis et al.,1999).
The intra-nuclear distribution of S186A mutant ZEBRA in BZKO and
2089 cells was similar to wild-type ZEBRA (Fig. 3: panels iii, vi). The
transfected S186A ZEBRA protein was conﬁned to the nucleus in a
ﬁnely-grained, relatively smooth, diffuse pattern. Sub-regions of
reduced or no mutant S186A ZEBRA staining were also observed.
However, unlikewild-type ZEBRA, the S186Amutant proteinwas never
observed in globular areas of increased ZEBRA staining. Therefore,
S186A does not lead to formation of replication compartments. Cells
expressing Z(S186A) never contained EA-D (Fig. 3: panels i, ii, iv, v), a
ﬁnding consistent with previous analyses by immunoblotting (Francis
et al., 1997; Adamson and Kenney, 1998; Heston et al., 2006).
In BZKO and 2089 cells the appearance of the ZEBRA early mutant,
R179A, was dramatically different than wild-type and S186A mutant
ZEBRA. Instead of the diffuse distribution of wild-type and S186A
ZEBRA, the R179A mutant localized to numerous small discrete
punctate foci within the nuclei (Fig. 3: panels ix, xii) of many cells.
These discrete foci were uniform in size and were, in general, evenly
spaced throughout the nucleus. Sub-regions with little or no ZEBRA
staining, consistent with nucleoli and similar to those observed with
WT and S186A, were often seen. No EA-D protein was seen in cells
expressing the R179A mutant (Fig. 3: panels vii, viii, x, xi), in
accordance with previous immunoblot studies (Heston et al., 2006;
Fig. 4). On a single cell level, transfection with wild-type ZEBRA and
the ZEBRA mutants resulted in a broad range of expression levels of
ZEBRA protein in individual cells. Some cells expressed relatively high
levels of ZEBRA protein and others expressed lower levels. Yet
regardless of the level of wild-type ZEBRA protein expressed in any
given cell, the discrete foci seen with R179A was not seen in cells
transfected with wild-type ZEBRA. This result shows that the speckled
mutant phenotype is not caused by reduced or increased levels of
protein. Thus, the arginine at position 179, in addition to being
required for transcriptional activation of some early and late genes, is
also essential for proper localization of ZEBRA. Mutation of R179 to
alanine dramatically alters the distribution of the protein within the
nucleus.
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Y180E also localized to numerous discrete punctate foci (Fig. 3: panels
xv, xviii) in a signiﬁcant proportion of ZEBRA-positive cells, producing
a ZEBRA distribution remarkably similar to the pattern observed withFig. 5. Comparison of intra-nuclear distributions ofwild-type andmutant ZEBRAproteins in 29
cells (iii, iv, vii, viii, xi, xii, xv, xvi, xix, xx) were transfected with expression plasmids for wild-t
(xvii–xx). Cells were ﬁxed and stained 42 h after transfection. 2089 cells were double stained f
indicates a discrete focus of mutant Y180E ZEBRA in a 293 cell.mutant R179A. The localization of EA-D following lytic cycle activation
by Y180E differed from that induced by wild-type ZEBRA protein.
Consistent with previous immunoblot experiments, Y180E ZEBRA
induced high levels of EA-D expression (Heston et al., 2006; Fig 4.).3 cells with andwithout EBV-bacmids. 2089 cells (i, ii, v, vi, ix, x, xiii, xiv, xvii, xviii) and 293
ype ZEBRA (i–iv), R179A (v–viii), Y180E (ix–xii), S186A (xiii–xvi), or K188R mutant ZEBRA
or ZEBRA and EA-D, and 293 cells were double stained for ZEBRA and lamin B. Red arrow
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induced by Y180E was distributed diffusely throughout the nucleus in
nearly all cells positive for EA-D (Fig. 3: panels xiii, xiv, xvi, xvii). In
2089 cells transfected with Y180E, a small percentage, approximately
3% (4 of 142 cells selected at random), of cells positive for EA-D
showedmature viral replication compartments, compared to approxi-
mately 28% (40 of 145 cells) of 2089 cells transfected with wild-type
ZEBRA. Mutation of the tyrosine at position 180 to glutamate
therefore, allows EA-D expression but prevents the formation of
replication compartments. Since the Y180Emutant is defective at lytic
viral DNA replication, these ﬁndings provide further evidence that
globules containing EA-D are sites of accumulation of lytically
replicated EBV DNA.
The WT mutant, K188R, activates Rta expression, early gene
expression, and late gene expression at levels similar to wild-type
ZEBRA (Heston et al., 2006; Fig. 4). Immunoﬂuorescence analysis of
BZKO and 2089 cells transfected with the K188R mutant showed
distributions of ZEBRA and EA-D proteinwhichwere indistinguishable
from cells transfected with wild-type ZEBRA. ZEBRA staining in
K188R-transfected cells was diffuse throughout the nucleus with a
relatively smooth texture. Small spared sub-regions where ZEBRA
staining was reduced or absent were interspersed within the diffuse
intra-nuclear staining (Fig. 3: panels xxi, xxiv;). As seen in wild-type
ZEBRA-transfected cells, the diffuse K188R ZEBRA staining was often
slightly, yet unmistakably, increased in areas co-localizing with
globular replication compartments. Thus, like wild-type ZEBRA,
K188R was also partially recruited to viral replication compartments
(Fig. 3: panel xxi; yellow arrow). EA-D staining in K188R-transfected
cells was also indistinguishable from wild-type ZEBRA induced cells.
In a signiﬁcant proportion of EA-D positive cells, EA-D was present in
discrete globular replication compartments (Fig. 3: panels xix, xx, xxii,
xxiii).
In 2089 cells transfected with wild-type ZEBRA, Rta localized to
mature globular replication compartments very similarly to EA-D (Fig.
1: panels xiii, xv, xvi). To determine the effects of the Y180E and K188R
ZEBRA mutants on Rta distribution, 2089 cells transfected with Y180E
ZEBRA or K188R ZEBRAwere observed for Rta expression at 42 h post-
transfection. Transfection with Y180E ZEBRA caused Rta to be
localized either diffusely and uniformly (Fig. 3: panels xxv–xxvii) or
diffusely but non-uniformly (Fig. 3: panels xxviii–xxx), as was seen
with EA-D. A small percentage (2.8%: 4 of 142 cells selected at random)
of cells positive for Rta expression did show localization to globular
compartments; however, this was markedly reduced from the 28% of
cells showing Rta in globular compartments in cells transfected with
wild-type ZEBRA. The few cells transfected with Y180E which showed
Rta in globules were also the only ones to show EA-D in globular
compartments. The Y180E mutation therefore allows Rta expression;
however, Rta is not found in globular replication compartments, as the
result of Y180E's failure to stimulate lytic DNA replication. The
distribution of Rta in 2089 cells transfected with K188R ZEBRAmutant
was the same as the distribution of Rta in cells transfected with wild-
type ZEBRA (Fig. 3: panels xxxi–xxxvi).
Phenotype of each mutant as assessed by immunoblotting
The immunoﬂuorescence analyses illustrated in Fig. 3 showed that
the intra-nuclear distribution of each ZEBRA mutant in 2089 cells,
containing a wild-type BZLF1 gene within the EBV-bacmid, was
identical to that seen in BZKO cells containing a bacmid in which the
BZLF1 gene was insertionally inactivated. The identity of the two EBV-
bacmids in the two cell lines was conﬁrmed by Southern blotting with
a probe of BamHI Z. The BZKO cells contained the diagnostic 3 kb
BamH1 fragment representing the insertionally inactivated BZLF1
gene and 2089 cells contained a wild-type BamH1 Z fragment (data
not shown). To verify that the mutant phenotypes observed in 2089
cells were consistent with previous characterization in BZKO cells,each ZEBRAmutant was assayed by immunoblotting for its capacity to
activate expression of downstream EBV lytic proteins, Rta, EA-D,
BFRF3, and BLRF2, in 2089 cells. Each ZEBRA mutant induced the
pattern of viral proteins expected for its kinetic class (Fig. 4). Probing
with antibody to ZEBRA showed that equivalent levels of proteinwere
being expressed by the wild-type and mutant ZEBRA genes (Fig. 4).
The maintenance of the mutant ZEBRA phenotype in 2089 cells
strongly suggests that the transfected mutant ZEBRA proteins did not
auto-stimulate the endogenous wild-type BZLF1 gene in these cells
(see Discussion).
Intra-nuclear distribution of ZEBRA basic domain mutants in 293 cells
lacking an EBV-bacmid
To observe the intracellular distribution of the ZEBRA mutants in
cells lacking an EBV genome, andmore speciﬁcally to test whether the
formation of punctate ZEBRA foci observed with the R179A and Y180E
mutations required additional viral factors, each ZEBRA mutant was
transfected into 293 cells devoid of an EBV-bacmid. In 293 cells wild-
type ZEBRA was observed to be in a diffuse ﬁne-grain intra-nuclear
distribution (Fig. 5: panel iv) that was similar to the distribution of
wild-type ZEBRA seen in 2089 cells (Fig. 5, panel ii). However, in 293
cells ZEBRA was not present in globular replication compartments as
seen in some 2089 cells. Transfection of S186A mutant into 293 cells
also produced a diffuse and smoothly textured intra-nuclear distribu-
tion (Fig. 5, panel xvi) which appeared to be identical to the
distribution seen in 2089 (Fig. 5, panel xiv) or BZKO cells, and was
indistinguishable from wild-type ZEBRA. Transfection of K188R
mutant into 293 cells, similarly to wild-type ZEBRA, produced a
diffuse ﬁne-grain intra-nuclear distribution (Fig. 5: panel xx) which
was very similar to the distribution seen in 2089 cells (Fig. 5, panel
xviii). Thus, the intra-nuclear distribution of wild-type, S186A, and
K188R mutant ZEBRA proteins was indistinguishable in EBV-positive
and EBV-negative 293 cells.
The distribution of R179A and Y180Emutant ZEBRA proteins in 293
cells differed from the smooth diffuse distribution of wild-type ZEBRA
and S186A in the same cells, and also differed from the discretely
speckled localization of these two mutants in cells containing EBV-
bacmids. In the nuclei of 293 cells, R179A and Y180E mutant ZEBRA
proteins were distributed non-uniformly. The localization patterns
ranged from partially diffuse, coarsely textured staining (Fig. 5, panel
viii) to a non-diffuse and uneven, lumpy distribution (Fig. 5, panel xii),
in which a few discrete punctate foci were seen (Fig. 5, panel xii: red
arrow). The non-uniform and uneven distribution of R179A and Y180E
proteins observed in 293 cells could be clearly distinguished from the
pattern of distinctly-deﬁned and evenly spaced discrete punctate foci
seen in 2089 and BZKO cells containing EBV-bacmids (Fig. 5, panels vi
and x). The differences in distribution of R179A or Y180E mutant
ZEBRA proteins in 293 cell backgrounds with and without an EBV
genome suggests two possibilities which are not mutually exclusive:
(1) the mutation in the basic domain itself may affect intra-nuclear
localization of ZEBRA protein, even in EBV-negative cells; or (2)
cellular and viral factors may partially contribute to the mutant
speckled phenotype seen in cells containing EBV-bacmids. The
inability of either R179A or Y180E mutant to produce in 293 cells
the numerous clearly distinct evenly distributed punctate foci which
were seen in 2089 or BZKO cells suggests that additional viral factors
conferred by lytic EBV infection are likely to be necessary to produce
the speckled phenotype (see Discussion).
Effect of viral DNA replication inhibitors, phosphonoacetic acid (PAA)
and acyclovir (ACV), on localization of ZEBRA and EA-D in cells
transfected with wild-type or R179A mutant ZEBRA
The next experiments attempted to determine whether the
speckled distribution of ZEBRA, observed with a mutant, such as
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with wild-type ZEBRA when lytic viral DNA replication was inhibited
by anti-viral drugs. During HSV-1 lytic infection the speckled pre-
replication compartment stage is transient (Quinlan et al., 1984), but
may be visualized by blocking progression of the lytic phase with viral
DNA replication mutants or by treatment with viral DNA replication
inhibitors such as phosphonoacetic acid (PAA) or acyclovir (ACV)
(Lukonis and Weller, 1996). To observe the effect of inhibiting viral
DNA synthesis on the localization of ZEBRA and EA-D proteins, both of
which are presumptive components of an EBV pre-replication
complex, 2089 cells were transfected with WT or R179A mutant
ZEBRA and treated with PAA or ACV (Fig. 6). In cells transfected with
WT ZEBRA and treated with PAA or ACV, ZEBRA staining remained
diffuse throughout the nucleus. ZEBRA was never seen in a speckled
distribution in the presence of the inhibitors of viral DNA replication.
Moreover, globular regions of increased ZEBRA staining were never
detected in cells treated with PAA or ACV.
The localization of EA-D in cells transfected with wild-type ZEBRA
and treated with PAA or ACV differed from the distribution of EA-D in
untreated cells. Whenever EA-D was seen in PAA/ACV-treated cells it
was diffusely present in the nucleus and never recruited to globular
structures (Fig. 6: panels iv, vii). Thus PAA or ACV blocked the
appearance of mature replication compartments which require lytic
viral DNA replication for their formation. As described in Fig. 2, 50% of
2089 cells transfected withWT ZEBRA, but not treated with inhibitors
of viral replication, contained diffuse intra-nuclear EA-D which was
not found in globular replication compartments. However, the diffuse
EA-D staining in PAA/ACV-treated cells differed from the smoothly
textured and relatively homogeneous diffuse staining seen in
untreated cells. PAA/ACV treatment caused EA-D staining to be non-
uniform and to consist of numerous clumped aggregations or foci (Fig.
6, iv and vii). These foci of EA-D clumps produced in the presence of
PAA and ACV were uneven in size, intensity, and spacing and did not
resemble the uniformly sized and evenly spaced punctate ZEBRA foci
seen with some ZEBRA mutants, such as R179A and Y180E.
PAA and ACV treatment did not alter the formation of discrete
punctate ZEBRA foci by the R179A ZEBRA mutant. The speckled
phenotype of R179A mutant ZEBRA in PAA/ACV-treated cells (Fig. 6:
panels xv, xviii) was indistinguishable from that observed in untreated
cells (Fig. 6: panel xii). These results show that viral DNA replication is
not required for formation of the speckled ZEBRA foci by the R179A
mutant. Moreover, since R179A does not activate BMRF1, the results
show that discrete punctate foci of ZEBRA are generated indepen-
dently of the presence of the viral polymerase processivity factor.
Intra-nuclear distribution of S186A mutant ZEBRA is not affected by
exogenous expression of Rta
The diffuse distribution of ZEBRA S186A mutant in 2089 cells
differs from the punctate distribution of ZEBRA induced by the R179A
and Y180E mutants. One possible reason for the different distribution
pattern of S186A, as compared with the R179A and Y180E mutants,
may lie in the inability of S186A to activate expression of Rta protein.
Therefore we further tested whether the diffuse distribution of the
S186A ZEBRA mutant was altered when Rta was exogenously co-
expressed with S186A mutant ZEBRA. Previous experiments have
shown that exogenous expression of Rta rescues BMRF1 transcrip-
tional activation by the S186A ZEBRA mutant (Francis et al., 1999;
Adamson and Kenney, 1998; Heston et al., 2006). 2089 cells co-
transfected with S186A and Rta-expression plasmids were stained for
ZEBRA and EA-D, as a marker for Rta activity. Cells co-transfected with
S186A and Rta showed bright EA-D staining, indicating that Rta wasFig. 6. Effect of phosphonoacetic acid (PAA) and acyclovir (ACV) treatment on the local
compartments. 2089 cells were transfected with wild-type ZEBRA (i–ix) or R179A mutant ZE
then ﬁxed and double stained for ZEBRA and EA-D.active (Fig. 7: panels iv, v). However in all cells positive for EA-D, the
protein was uniformly and diffusely distributed throughout the intra-
nuclear space, and not in globular replication compartments.
Exogenous expression of Rta did not affect the distribution of S186A
mutant ZEBRA which remained diffusely and smoothly distributed
throughout the intra-nuclear space (Fig. 7, panel vi). These results
showed that the diffuse distribution of Z(S186A) is an intrinsic
property of the mutant protein and is not correlated with its failure to
activate Rta or EA-D expression.
To test whether the diffuse distribution of the S186A mutant
ZEBRAwas common to other ZEBRA mutants deﬁcient at activation of
Rta and EA-D, we studied the distribution of two additional mutants,
K181A and A185V. Both mutants bind ZIIIB DNA relatively weakly;
K181A binds 37% and A185V 10% as actively as wild-type (Heston et al.,
2006). K181A activates low levels of Rta and A185V activates only
trace levels of the protein. Transfection of K181A (Fig. 7, panel ix) or
A185V (Fig. 7, panel xii) into 2089 cells resulted in a discrete punctate
distribution of ZEBRA similar to that seen with the R179A and Y180E
mutants. The localization of S186A mutant ZEBRA therefore differed
from other Rta-deﬁcient ZEBRA mutants.
We also compared the distribution of the S186A mutant with the
distribution of another mutant at the same position, S186E. Both
mutations completely abolish ZEBRA's capacity to disrupt latency;
however, the S186A mutant retains its capacity to bind ZIIIB DNA,
whereas S186E does not bind ZIIIB DNA (Heston et al., 2006). The
distribution of S186E ZEBRA appeared similar to S186A (Fig. 7, panel
xv). S186E was smoothly and diffusely distributed throughout the
intra-nuclear space; no discrete puncta were seen in any cell; and as
was seen with S186A, sub-regions of reduced S186E staining were
present. These results make it unlikely that the diffuse distribution of
S186A is directly related to its capacity to bind DNA.
Intra-nuclear distribution of wild-type and R179A mutant ZEBRA in
D98/HR-1 cells
The speckled distribution of ZEBRA mutants, such as R179A and
Y180E, in 293 cells containing EBV-bacmids is a new phenomenon.
Therefore we wished to investigate whether speckle formation
speciﬁc to certain ZEBRA mutants could be observed in other cell
backgrounds. To determine whether WT or R179A mutant ZEBRA
would form discrete speckled punctate foci in other cell lines infected
with EBV, we examined ZEBRA and EA-D localization in D98/HR-1
cells transfected with WT ZEBRA or R179A mutant ZEBRA (Fig. 8). The
distribution of WT ZEBRA and EA-D in D98/HR-1 cells was similar to
that observed in 2089 and BZKO cells (Fig. 1). ZEBRA staining was
ﬁnely grained, relatively smooth in texture, and distributed diffusely
throughout the nucleus (Fig. 8: panels iii, vi). ZEBRA was not
completely recruited to replication compartments in ZEBRA-trans-
fected D98/HR-1 cells. However, as was seen in BZKO and 2089 cells, in
many D98/HR-1 cells which showed mature globular replication
compartments, as visualized by EA-D staining (Fig. 8: panel i), the
diffuse ZEBRA staining was slightly but unmistakably increased in
areas coincident with the globular replication compartments (Fig. 8:
panel iii; yellow arrow). Thus, ZEBRA was partially recruited to viral
replication compartments. However, in some D98/HR-1 cells contain-
ing globular replication compartments, as in the 293 cells with EBV-
bacmids, ZEBRA was not increased at the site of EA-D globules (data
not shown).
Three patterns of EA-D staining were seen in D98/HR-1 cells
analyzed 42 h after transfectionwithWT ZEBRA. These resembled the
patterns in BZKO and 2089 cells (Fig. 2). In some cells intra-nuclear
EA-D was diffusely distributed (Fig. 8: panels iv, v); in other cells EA-Dization of wild-type and R179A mutant ZEBRA and on the formation of replication
BRA (x–xviii), treated with 500 μM PAA (iv–vi, xiii–xv) or 50 μM ACV (vii–ix, xvi–xviii),
Fig. 7. Intra-nuclear distribution of ZEBRAmutantswhich are defective at activation of Rta andEA-D. 2089 cellswere transfectedwith S186Amutant ZEBRA (i–iii), S186Aplus Rta (iv–vi),
K181A mutant ZEBRA (vii–ix), A185V mutant ZEBRA (x–xii), or S186E mutant ZEBRA (xiii–xv). Cells were ﬁxed and double stained for ZEBRA and EA-D.
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panels i, ii); and other cells contained unevenly distributed EA-D (not
shown).Fig. 8. Nuclear localization, activation of EA-D, and replication compartment formation by w
with wild-type ZEBRA (i–vi) or R179A mutant ZEBRA (vii–xviii). Cells were ﬁxed and doubl
ZEBRA staining.D98/HR-1 cells transfected with R179A ZEBRA showed a spectrum
of nuclear morphological characteristics. One cellular subpopulation
stained positively for ZEBRA and were negative for EA-D. In many ofild-type and R179A mutant ZEBRA in D98/HR-1 cells. D98/HR-1 cells were transfected
e stained for ZEBRA and EA-D. Yellow arrows indicate nuclear sub-regions of increased
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foci in the intra-nuclear space (Fig. 8: panel ix). In this subpopulation
of D98/HR-1 cells the phenotype of R179A mutant ZEBRA resembled
the phenotype seen in BZKO and 2089 cells (see Fig. 3, panels ix, xii).
Another subpopulation of D98/HR-1 cells transfected with R179A
ZEBRA stained positively for EA-D protein and for ZEBRA (Fig. 8:
panels x, xiii, xvi). This population was never observed in BZKO or
2089 cells. Some of the EA-D-positive D98/HR-1 cells observed after
transfection of R179A displayed a wild-type phenotype: EA-D was
localized to globular replication compartments (Fig. 8: panels x, xi);
ZEBRA was distributed diffusely throughout the intra-nuclear space
(Fig. 8: panel xii) and regions of increased ZEBRA staining co-localized
with replication compartments (Fig. 8: panel xii, yellow arrow). In
another pattern, also similar to a pattern observed with WT ZEBRA in
293 cells with the EBV-bacmids, both EA-D and ZEBRA were
distributed diffusely and uniformly throughout the nucleus (Fig. 8:
panels xiii–xv; compare Fig. 1). Because the R179A mutant itself is
incapable of activating BMRF1 expression in cells containing EBV-
bacmids, the presence of BMRF1-positive cells following transfection
of R179A ZEBRA into D98/HR-1 cells suggests that the R179A mutant
auto-stimulates the endogenous wild-type BZLF1 gene in this cell
background. The two patterns of EA-D distribution, globular and
diffuse, can be attributed to auto-activation of the endogenous BZLF1
gene (see Discussion).
A novel pattern of EA-D and ZEBRA distribution, never observed in
the 293 cell/EBV-bacmid system, was also seen in some EA-D-positive
D98/HR-1 cells after transfection of the R179A mutant. In these cells
EA-D was localized to many heavily staining globular replication
compartments amidst a more lightly stained diffuse smoothly
textured surrounding intra-nuclear space (Fig. 8: panel xvi). In the
same cells, ZEBRA was also heavily concentrated in replication
compartments, amidst a lighter stained surrounding intra-nuclear
space (Fig. 8: panel xviii). However, in replication compartments and
in the lightly stained surrounding space ZEBRA had a deﬁnite speckled
pattern. Cells of this type seemed to exhibit a mixture of both the
discrete punctate R179A mutant phenotype and the wild-type ZEBRA
phenotype.
Discussion
As the major EBV lytic regulatory protein, ZEBRA functions within
the nucleus as a transcriptional activator and as a lytic DNA replication
origin-binding protein. In our previous study, a series of point
mutations introduced into the basic DNA-recognition domain of
ZEBRA were characterized with respect to the resulting defects in
transcriptional activation and DNA replication (Heston et al., 2006). In
this study we further investigated the effects of some of these
mutations on the intra-nuclear distribution of ZEBRA protein, and on
the formation of replication compartments. We found that speciﬁc
amino acid changes within the basic domain are associated with
speciﬁc changes in ZEBRA localization, and also inﬂuence the
formation of mature replication compartments. The mutants can be
grouped into four classes based on these morphological changes
(Table 1). Several amino acid substitutions altered the localization of
ZEBRA from its typical diffuse distribution into a speckled phenotype
containing numerous, small, discrete, evenly spaced and evenly sized
foci. The speckled phenotype of one group of mutants (i.e. K181A,
A185V, and R179A) was accompanied by a defect in ZEBRA's capacity
to activate Rta or EA-D; whereas other mutants with a speckled
distribution (i.e. Y180E and K188A) induced expression of EA-Dwhich,
however, was not recruited to globular replication compartments. A
third distinct class of ZEBRA mutations at position S186 was diffusely
distributed in the nucleus in a pattern reminiscent of wild-type
protein; however, S186A and S186E did not induce Rta or downstream
viral genes, and did not form replication compartments. A fourth class
of mutation (i.e. K188R), found in our earlier study to have no defectsin transcriptional activation or DNA replication (Heston et al., 2006),
had a normal diffuse intra-nuclear distribution of ZEBRA and
promoted globular replication compartment formation. Thus, this
group of ZEBRA mutants not only arrest the EBV lytic cycle at distinct
stages, they are distributed in distinct patterns in the nucleus,
suggesting that they induce distinct phases of nuclear re-organization.
Cell background considerations in analysis of the intra-nuclear
distribution of ZEBRA mutants and formation of
replication compartments
We found that the 293 cell/EBV-bacmid system is particularly well
suited for analysis of the intracellular distribution of mutant ZEBRA
proteins. Since the BZLF1 gene is disrupted in the BZKO cell line, there
is no endogenous ZEBRA expressed and all the ZEBRA protein is made
from the transfected plasmid. However, some BZKO cells which
expressed wild-type ZEBRA did not express EA-D. The failure of ZEBRA
expression to be accompanied by signs of EBV lytic activation is likely
to be due to loss of the EBV-bacmid from some BZKO cells. The EBV-
bacmid appears to be more stably maintained in 2089 cells.
Remarkably, all the mutant ZEBRA phenotypes which were observed
in BZKO cells were preserved in 2089 cells, which was shown to
contain an intact BZLF1 gene (Figs. 3 and 4, and data not shown). It is
likely that none of the ZEBRA mutants directly auto-stimulated the
endogenous BZLF1 gene in 2089 cells; however it is also possible that
overexpression of the transfected mutant ZEBRA proteins may have
had a dominant-negative effect or have masked wild-type ZEBRA
protein expressed from the endogenous BZLF1 gene. Since many of
these mutants also activated Rta expression, Rta did not cross-activate
BZLF1 in 2089 cells, as it does in some cell backgrounds.
The intra-nuclear distribution of ZEBRA mutants was also studied
in 293 cells that did not contain EBV-bacmids. These experiments (Fig.
5) showed that nuclear localization of ZEBRA and all the mutants was
independent of the presence of EBV gene products. The appearance of
wild-type, S186A, and K188R mutants was identical in 293 cells with
andwithout EBV. However, the discrete speckled appearance of R179A
and Y180E was only observed in EBV-positive 293 cells. These
mutants, however, were distributed unevenly in the nuclei of 293
cells. This experiment suggests that in some instances the mutations
themselves may affect intra-nuclear location, independent of any
effects the mutations may have on the EBV life cycle.
Parallels between HSV-1 and EBV in formation of the viral DNA
replication complex
Parallels have been demonstrated between EBV and HSV-1 in the
composition of and the process of formation of the core viral replication
complex. As a DNA replication protein, ZEBRA binds to oriLyt and
recruits other viral replication proteins to oriLyt. The assembly of this
core replication complex at oriLyt allows initiation of viral DNA
synthesis. Formation of the replication complex relies on many
different contact points between ZEBRA and the individual core
replication proteins. The EBV helicase (BBLF4), primase (BSLF1), and
primase-associated factor (BBLF2/3) directly bind each other to form a
tripartite complex that interactswith the viral polymerase (BALF5) (Gao
et al., 1998; Yokoyama et al., 1999; Fujii et al., 2000). The primase sub-
complex (BSLF1–BBLF2/3) interactswith theN-terminus of ZEBRA (Gao
et al., 1998); the EBV helicase (BBLF4) interacts with an adjacent but
separate region of ZEBRA (Liao et al., 2001). EA-D (the polymerase
processivity factor) interacts with both BALF5 and ZEBRA (Kiehl and
Dorsky,1991; Li et al.,1987; Zhang et al.,1996), and the single-stranded
DNA-binding protein (BALF2) interacts with the EA-D–BALF5 complex
(Zeng et al., 1997). Similar interactions among the homologous core
replication proteins of HSV-1 have been demonstrated (Marsden et al.,
1997; McLean et al., 1994; Hamatake et al., 1997). The origin-binding
function of ZEBRA is assumed by the HSV-1 UL9 proteinwhich contacts
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encoded replication proteins would be expected to be present in the
globular replication compartments. In our experiments, thus far, we
ﬁnd ZEBRA (BZLF1), EA-D (BMRF1) and Rta (BRLF1) in replication
compartments (Figs.1, 3).We do not yet understand the role of EBV-Rta
in replication.
Effects of inhibiting HSV-1 and EBV DNA synthesis on the formation of
viral pre-replication sites and mature replication compartments
When HSV-1 lytic replication is blocked, either by treatment with
viral DNA synthesis inhibitors such as PAA or ACV, or by infection with
viral DNA replication-defective mutants, mature replication compart-
ments donot form. Instead, the core viral replicationproteins localize to
numerous discrete punctate foci that assume a speckled intra-nuclear
distribution (Liptak et al., 1996). These punctate foci, which are often in
close association with ND10 or PML bodies, have been termed pre-
replicative sites, and represent the precursors to mature globular viral
replication compartments. Time lapse microscopy shows that the
numerous HSV-1 pre-replication foci actively coalesce and accrue to
form larger mature globular replication compartments (Taylor et al.,
2003). Transfection of four HSV-1 replication proteins (the helicase,
primase, primase-associated factor, and polymerase processivity
factor) is sufﬁcient to form pre-replicative sites even in uninfected
cells (Uprichard and Knipe, 1997); however, in virally infected cells the
origin-binding protein is also required (Lukonis et al., 1997).
In our studies, in parallel with those in HSV-1, the formation of
mature replication compartments was blocked in 293/EBV bacmid
cells transfected with wild-type ZEBRA and treated with inhibitors of
viral DNA replication (Fig. 6). However, PAA or ACV treatment of 2089
cells induced into the lytic cycle by WT ZEBRA did not reproduce, in
our experiments, the speckled appearance of HSV-1 pre-replication
sites or the speckled distribution of some ZEBRA mutants (Fig. 6,
panels vi, ix). Instead, a non-uniform clumped intra-nuclear distribu-
tion of EA-D was seen in 2089 cells that expressed ZEBRA and were
treated with PAA or ACV (Fig. 6, panels iv, vii). The non-uniform and
clumped distribution of EA-D in cells treated with inhibitors of lytic
replication suggests that discrete pre-replication foci were present
and were in the process of coalescing to form mature replication
compartments. The absence of punctate ZEBRA foci may indicate that
ZEBRA's association with the replication complex, or with oriLyt, is
transient. ZEBRA, which might act as a tether for the replication
complex by virtue of its high afﬁnity for oriLyt DNA, would be
expected to dissociate rapidly from the fully assembled replication
complex, perhaps immediately following recruitment of the viral DNA
polymerase, in order to allow movement of the complex along the
template DNA. The inhibitory effects of PAA and ACV would exert
themselves after the replication complex is fully assembled; thereafter
ZEBRA would dissociate from the DNA and would be diffusely
distributed. The speckle-forming mutants of ZEBRA, however, may
block progression of assembly of the core replication complex at a
stage before the dissociation of ZEBRA from the DNA. In support of this
hypothesis, the mutant R179A remains in a speckled distribution in
2089 cells treated with PAA or ACV (Fig. 6, panels xv, xviii). This
ﬁnding suggests that the R179A speckles are formed prior to the
events which are inhibited by PAA and ACV. The events sensitive to
these inhibitors involve the viral DNA polymerase. Therefore it may be
assumed that Z(R179A) does not activate expression or interact
properly with BALF5.
The speckled distribution of ZEBRA mutants may represent
pre-replication foci
The composition of the speckled foci formed by mutant ZEBRA
proteins, and the mechanism underlying their formation is not yet
known. All the mutations with a speckled distribution halt theprogression of the lytic cascade at early stages of viral gene expression,
before lytic viral DNA synthesis (Heston et al. 2006). Therefore, it
seems possible that the speckled distribution may represent a
transient intermediary stage of ZEBRA localization, corresponding to
a pre-replication phase for EBV as has been observed for HSV-1 (de
Bruyn Kops and Knipe, 1988; Quinlan et al., 1984). Several lines of
evidence support the hypothesis that the speckled distribution of
some ZEBRA mutants represents EBV pre-replication foci. The
speckled distribution of ZEBRA mutant Y180E was accompanied by
two other deﬁciencies which point to a defect during lytic DNA
replication in the assembly or function of the viral core replication
complex: (i) 2089 cells transfected with Y180E were incapable of
developingmature globular replication compartments, despite having
normal expression levels of the polymerase processivity factor, EA-D
(Fig. 3, panels xiii, xvi). (ii) The Y180E mutant lacks the ability to
stimulate lytic viral DNA synthesis (Heston et al., 2006.). These two
defects were also characteristic of another late mutant, K188A, which
formed speckles similar to Y180E (data not shown).
A third observation which supports the hypothesis that speckles
formed by mutant ZEBRA proteins represent pre-replication sites, as
opposed to aberrant recruitment of mutant ZEBRA to pre-existing
cellular structures, is that the characteristically distinct speckled
distributions of the R179A and Y180E mutations seen in 2089 and
BZKO cells were not seen in 293 cells lacking EBV (Fig 5, panels VIII,
XII). This observation would indicate that the speckled distribution of
mutant ZEBRA is not an intrinsic effect of the mutation alone, but
rather requires the presence of additional viral factors or virally
induced changes to the host cell. It should also be noted, however, that
the roughly textured distribution pattern of the R179A and Y180E
mutants in 293 cells differed from the smooth, even distribution seen
with wild-type ZEBRA in the same cell type. Thus the speckled
phenotype may reﬂect both intrinsic qualities of the mutant ZEBRA
protein and accompanying alterations in cellular or viral structures.
One difﬁculty with the hypothesis that the speckled ZEBRA
distribution represents pre-replicative sites is that some ZEBRA
mutants which appeared in speckles i.e. R179A, K181A and A185V
arrest the EBV lytic cycle at very early stages, after Rta but before EA-D
expression (Fig. 3; Table 1). If, in amanner similar to HSV-1, four or ﬁve
EBV replication proteins must be expressed in order to form speckled
pre-replication sites, these early mutants would be expected to induce
expression of these replicative proteins. If they are found not to induce
expression of these replication proteins, then the formation of
speckled EBV pre-replication sites may occur by a mechanism that
differs from HSV-1. Alternatively, the mutant ZEBRA speckles may
represent structures other than pre-replication foci. The pre-replica-
tion speckles observed in HSV-1 infection have been deﬁned by ICP8,
the single-stranded DNA-binding protein homologue of EBV BALF2,
whereas ZEBRA is a functional homologue of HSV-1 UL9, the origin-
binding protein.
Hypotheses explaining the diffuse distribution of mutant Z(S186A) and
Z(S186E)
The smooth distribution of the S186A and S186E ZEBRAmutants in
2089 cells contrasts with the speckled distribution seen with several
other ZEBRA mutants (Fig. 5). This observation may contribute to
understanding the mechanism by which speckled foci are generated.
The difference between the sub-nuclear localization of S186 mutants
and speckle-forming ZEBRA mutants may not be attributable to
differences in binding to DNA. Although the S186Amutant is defective
in binding to ZREs which contain a methylated CpG (Bhende et al.,
2005), this mutant retains the ability to bind many other ZRE's as well
as, or better than, wild-type or speckle-formingmutants (Francis et al.,
1997; Heston et al., 2006; Adamson and Kenney, 1998). Furthermore,
S186E does not bind DNA, yet is also diffusely distributed throughout
the nucleus. S186A and S186E both differ, however, from other DNA-
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gene expression. This ﬁnding suggested that some viral gene
expression is required for formation of the speckled distribution of
ZEBRA. Since a major difference between S186A and other DNA-
binding ZEBRA mutants is an inability to induce expression of Rta, we
explored the effect of co-transfection of Rta (Fig. 7). Co-transfection of
Rta with S186A rescued expression of EA-D; however addition of Rta
did not alter the diffuse distribution of S186A or EA-D (Fig. 7, panels iv,
v, vi). Thus expression of Rta and EA-D alone are not sufﬁcient for
production of the speckled ZEBRA phenotype. It is likely that other
viral or cellular proteins not induced by the combination of S186A and
Rta are required for production of the speckled phenotype.
It is possible that S186A, by itself or in combination with Rta and
EA-D, does not activate expression of one or more members of the
tripartite helicase–primase complex necessary for generation of HSV-
1 or EBV pre-replication sites (Uprichard and Knipe, 1997). Other
ZEBRA mutants, such as R179A and Y180E, may induce expression of
these proteins to levels sufﬁcient for speckle formation. Experiments
analyzing the levels of expression of each of the viral replication
proteins induced by these ZEBRA mutants may provide an answer to
this question.
Historical insights into the intra-nuclear re-distribution of the EBV DNA
polymerase processivity factor
In classical experiments the Henles described EA-D as “early
antigen-diffuse” in Raji cells superinfected with the P3J-HR-1strain of
EBV (Henle et al., 1971). We now know that the EBV DNA in Raji cells
does not undergo lytic replication of EBV DNA due to a deletion in
BALF2, the EBV gene encoding the single-stranded DNA-binding
protein (Zhang et al., 1988; Decaussin et al., 1995). Therefore, Raji cells
induced into the lytic cycle express early but not late viral proteins.
Moreover, the P3J-HR-1 strain of EBV which induced EA-D in Raji cells
contains “het DNA” from which BZLF1, the ZEBRA gene, is constitu-
tively expressed as a result of rearrangement of the viral DNA (Miller
et al., 1985; Rooney et al., 1988). Therefore, the ZEBRA protein is
responsible for activating EBV lytic gene expression after super-
infection of Raji cells. Furthermore, when introduced into Raji cells on
stable oriP plasmids, ZEBRA activates early but not late EBV gene
expression (Gradoville et al., 1990).
We observed EA-D in a diffuse distribution in the nuclei of cells
under the following experimental conditions: 1) in some BZKO, 2089
or D98/HR-1 EA-D positive cells transfected with WT ZEBRA (Figs. 2,
8); 2) in all EA-D-positive cells expressing the ZEBRA mutant Y180E
which activates early but not late EBV genes; 3) in cells treated with
PAA or ACV and transfected withWT ZEBRA (Fig. 6); and 4) in cells co-
expressing the S186A mutant and Rta (Fig. 7). This combination
activates early genes but does not activate late genes (Adamson and
Kenney, 1998). Thus, as surmised by the Henles, when EA-D is
diffusely distributed throughout the nucleus, it is a marker for the
early stages of viral gene expression, preceding viral replication.
A dramatically different distribution of EA-D in globular replication
compartments was observed following transfection of WT ZEBRA or
the K188R WT mutant into BZKO, 2089 or D98/HR-1 cells (Figs.
1,2,3,5,8). Globular EA-D was also observed in D98/HR-1 cells trans-
fected with the R179A early mutant, probably as the result of auto-
stimulation of the endogenousWT ZEBRA (Fig. 8). Globular replication
compartments were not observed under conditions known to block
late gene expression, including transfection of the late-mutant Y180E,
treatment with inhibitors of lytic replication, or co-expression of
S186A and Rta. Thus, the presence of EA-D in globular replication
compartments is a marker for late phases of the viral life cycle, during
or after lytic DNA replication. At late stages the distribution of EA-D is
neither “early” nor “diffuse”. The ﬁndings suggest that two different
functions for the BMRF1 gene product may be accompanied by two
different intra-nuclear distributions. At early times, when it is distri-buted diffusely in the nucleus, the protein may act as a transcription
factor, as previously suggested (Zhang et al., 1996). At late times, when
present in globular compartments, it may serve its role as the DNA
polymerase processivity factor.
The cellular components of the replication globules are poorly
characterized. Recently several cellular DNA repair proteins were
found to be recruited to EBV replication compartments (Kudoh et al.,
2005; Daikoku et al., 2006); however, the role of DNA repair
mechanisms in lytic viral replication is poorly understood. Signals
which cause re-location of EA-D to these compartments, the
mechanisms, the motor and the scaffolds for this dramatic process
of nuclear re-organization remain to be elucidated. ZEBRA mutants
which facilitate or inhibit the development of globular replication
compartments will be effective tools in dissecting the mechanisms
involved in development of these critical intra-nuclear structures and
in elucidating the complex process of EBV lytic DNA replication.
Materials and methods
Cell lines
293 is a human embryonic kidney cell line immortalized by the
early region of adenovirus (Van der Eb et al., 1977). 2089 is a 293
cell line stably transfected with a bacmid containing the full-length
EBV genome and a hygromycin B-resistance gene. BZKO is a 293 cell
line containing an EBV-bacmid in which the BZLF1 gene has been
inactivated by insertion of a kanamycin resistance cassette (Feederle
et al., 2000). D98/HR1 is a cell line generated by fusion of a human
epithelial cell line, D98, and an EBV-positive Burkitt's lymphoma cell
line, P3HR1 (Glaser and O'Neill, 1972). 293 cells were maintained in
RPMI 1640 complete media, supplemented with 10% fetal bovine
serum, 50 U/mL penicillin–streptomycin, and 1 μg/mL amphotericin
B. 2089 cells and BZKO cells were maintained in RPMI 1640
complete media containing 100 μg/mL hygromycin B (Calbiochem).
D98/HR1 cells were maintained in Dulbecco's modiﬁed minimal
essential complete media supplemented with MAGGT (0.6 μM
methotrexate, 50 μM adenosine, 50 μM guanosine, 0.1 mM glycine,
16 μM thymidine).
Antibodies
In immunoﬂuorescence experiments, ZEBRA was detected with a
polyclonal antibody (S1605-1) prepared from rabbits immunized with
puriﬁed full-length ZEBRA. ZEBRA protein was expressed in E. coli from
a pET22b vector containing the BZLF1 gene and puriﬁed over a nickel-
agarose column. EA-D was detected using the mouse monoclonal
antibody R3.1 (Pearson et al., 1983). In immunoblot experiments,
ZEBRA was detected using a rabbit polyclonal antibody described
previously (El-Guindy and Miller, 2004). Rta and BLRF2 protein were
detected using rabbit polyclonal antisera described previously (Heston
et al., 2006). BFRF3 was detected with a rabbit polyclonal antibody
(S1931-1) raised against full-length BFRF3 protein expressed and
puriﬁed from E. coli. Lamin B was detected using a commercially
available goat polyclonal antibody (Santa Cruz; sc-6216). Antibodies to
nucleolin (ab13541) and ﬁbrillarin (ab18380) were purchased from
Abcam. The following secondary antibodies, used in immunoﬂuores-
cence experiments, were purchased from Jackson ImmunoResearch
Laboratories, Inc.: FITC-conjugated sheep anti-mouse IgG (#515-095-
062), Texas Red-conjugated donkey anti-rabbit IgG (#711-075-152),
FITC-conjugated donkey anti-goat IgG (#705-095-147).
Indirect immunoﬂuorescence
Cells were grown on glass coverslips and transfected with plasmid
DNA using DMRIE-C reagent (Invitrogen). After 8 h the transfection
reagent was replaced with growth media. In certain experiments,
161R. Park et al. / Virology 382 (2008) 145–162growthmedia contained 500 μMphosphonoacetic acid (PAA) or 50 μM
acyclovir (ACV). Forty one hours after transfection, a time previously
determined to be adequate for detection of lytic viral DNA replication,
cells were ﬁxed in methanol for 30 min. at −20 °C, washed with PBS,
and incubated in blocking solution (10% human serum in PBS) for 1 h
at room temperature. Cells were stained with primary antibody
diluted in blocking solution for 1 h at room temperature in humidiﬁed
chambers. Cells were washed with PBS, then incubated with
secondary antibody diluted 1:200 in blocking solution for 1 h at
room temperature in opaque humidiﬁed chambers. Cells werewashed
with PBS, brieﬂy rinsed in distilled H2O to remove salts, thenmounted
on glass slides using Vectashield mounting media (Vector Labora-
tories). An Olympus confocal laser scanningmicroscopewith Fluoview
software was used to obtain digital images of ﬂuorescence and
transmitted light. Excited ﬂuorophore emissions were collected either
individually, or simultaneously under detection settings which
reduced cross-talk between the green and red channels to non-
detectable levels.
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